#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.

Cholesterol metabolism in the brain functions as a distinct, closed system, largely independent of peripheral plasma levels. While peripheral cholesterol is transported via APOB-containing lipoproteins, the brain relies on glial cells—specifically astrocytes and oligodendrocytes—to synthesize and distribute cholesterol through APOE-containing lipoproteins. Dysfunctional cholesterol transport, particularly in individuals with the APOE4 genotype, impairs neuronal cell membrane integrity, which accelerates the production of toxic beta-amyloid and tau proteins associated with Alzheimer's disease. Although the brain is highly protective of its cholesterol stores, pharmacological interventions like statins can cross the blood-brain barrier to modulate synthesis, while emerging CETP inhibitors show potential in improving Alzheimer's-related biomarkers. Understanding these unique physiological mechanisms is critical for developing targeted therapies that address neurodegenerative disease risk without compromising essential brain function.